Business News · News
Pfizer to combine off-patent drug business with Mylan
As reported by CNBC, Pfizer is set to combine its off-patent drug business with Mylan– a generic drugmaker. Pfizer shareholders would own 57% of…
Explore the publication
Latest news, case briefs, interviews and analysis tagged Off-Patent Drug.
1 article
Business News · News
As reported by CNBC, Pfizer is set to combine its off-patent drug business with Mylan– a generic drugmaker. Pfizer shareholders would own 57% of…